Lilly Laid Groundwork For Abbott's Defeat Of J&J's Patent Verdict On Humira

Abbott Laboratories had reason to thank Eli Lilly & Co. when the U.S. Court of Appeals for the Federal Circuit overturned a record $1.67-billion jury verdict that Abbott's Humira infringed a Johnson & Johnson patent.